SLBT

SL Science Holding Limited
CAPPED RATING

SL Science Holding Limited (SLBT) is rated C- (2.1/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B-); its weakest is Momentum (F). The rating has held at C- for 3 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.1 / 5.0
C-
Value
B-
Factor Score 3.0 / 5.0
Growth
D+
Factor Score 1.7 / 5.0
Profitability
B-
Factor Score 2.9 / 5.0
Momentum
F
Factor Score 0.5 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA 0.1
Rev Growth YoY -7.6%
Gross Margin 38.4%
Price Return 3M -73.7%
Price Return 12M -93.0%
Catalyst Signal 0.00
Market Cap $407.7M
TTM Revenue $3.3M
Price / Sales 124.7
ROE N/A

Historical Factor Score Progression

Held C- for 3 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B- (3.0) D+ (1.7) B- (2.9) F (0.5) C+ (2.6) C- (2.1)
2026-11-07 C- (2.0) D+ (1.7) B- (2.9) F (0.5) C+ (2.7) C- (2.0)
2026-10-31 D+ (1.7) D+ (1.7) B- (2.9) F (0.5) C+ (2.7) C- (1.9)
2026-10-24 D+ (1.8) D+ (1.7) B- (2.9) F (0.6) C+ (2.6) C- (1.9)
2026-10-17 D (1.4) D+ (1.7) B- (2.9) F (0.6) C+ (2.6) D+ (1.8)
Page 1 of 4